30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Biotechnology & Medical Research

MetaVia Inc (MTVA)

Track

The most recent insider trading activity occurred on June 4, 2025, with the Chief Financial Officer purchasing shares. Prior to this, significant buy transactions were noted in May 2025 by DONG-A ST CO., LTD. Older transactions include a sell in September 2024 and several buy transactions from 2016-2018.
Stock chart
Ticker: MTVA Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Woodworth Marshall H
Chief Financial Officer
1 purchase — total 9,940 USD
Buy 4 Jun 2025
Value US$601,216.85 | Price 406.93 | Shares 47,862
Buy 8 May 2025
Value US$1,074,857.49 | Price 480.47 | Shares 93,868
Sale 12 Sep 2024
Value US$1,526.25 | Price 3.75 | Shares 407
Buy 23 Jun 2024
Value US$7,964,378.90 | Price 3.13 | Shares 2,544,530
Buy 8 Feb 2018
Value US$100,002.00 | Price 7.00 | Shares 14,286
Buy 8 Feb 2018
Value US$500,003.00 | Price 7.00 | Shares 71,429
Buy 10 Mar 2017
Value US$236,750.00 | Price 9.47 | Shares 25,000
Buy 10 Mar 2017
Value US$499,997.06 | Price 9.47 | Shares 52,798
Buy 10 Mar 2017
Value US$99,993.73 | Price 9.47 | Shares 10,559
Buy 10 Mar 2017
Value US$199,996.93 | Price 9.47 | Shares 21,119
Buy 10 Aug 2016
Value US$250,000.00 | Price 10.00 | Shares 25,000
Buy 10 Aug 2016
Value US$5,000,000.00 | Price 10.00 | Shares 500,000
Buy 10 Aug 2016
Value US$525,000.00 | Price 10.00 | Shares 52,500
Buy 10 Aug 2016
Value US$40,000.00 | Price 10.00 | Shares 4,000
Buy 10 Aug 2016
Value US$517,500.00 | Price 10.00 | Shares 51,750
Buy 10 Aug 2016
Value US$100,000.00 | Price 10.00 | Shares 10,000
Buy 10 Aug 2016
Value US$10,000.00 | Price 10.00 | Shares 1,000
Buy 10 Aug 2016
Value US$40,000.00 | Price 10.00 | Shares 4,000
Buy 10 Aug 2016
Value US$111,200.00 | Price 10.00 | Shares 11,120
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2025-06-04 2025-06-04 B Purchase
1.6
Woodworth Marshall H

Chief Financial Officer

Officer
47,862 -3.9%
406.93
US$601,217 		47,862 -3.9% 406.93 US$601,217
2025-05-20 2025-05-08 B Purchase
2.1
DONG-A ST CO., LTD
Large shareholder
93,868 +1.8%
480.47
US$1,074,857 		93,868 +1.8% 480.47 US$1,074,857
2024-09-20 2024-09-12 S Sale
2.1
DONG-A ST CO., LTD
Large shareholder
84,363 +13.4%
373.35
US$449,526 		84,363 +13.4% 373.35 US$449,526
2024-06-25 2024-06-23 B Purchase
2.1
DONG-A ST CO., LTD
Large shareholder
2,544,530 +90.8%
3.13
US$7,964,379 		2,544,530 +90.8% 3.13 US$7,964,379
2018-02-12 2018-02-08 B Purchase Reno Seth

Chief Commercial Officer

Officer
14,286 +357.1%
7.00
US$100,002 		14,286 +357.1% 7.00 US$100,002
2018-02-12 2018-02-08 B Purchase Gullans Steven R. Ph.D.

Interim President & CEO

Executive Director
71,429 +8.3%
7.00
US$500,003 		71,429 +8.3% 7.00 US$500,003
2017-03-14 2017-03-10 B Purchase Hawryluk P. Kent
25,000 +43.9%
9.47
US$236,750 		25,000 +43.9% 9.47 US$236,750
2017-03-14 2017-03-10 B Purchase Gullans Steven R. Ph.D.
52,798 +6.6%
9.47
US$499,997 		52,798 +6.6% 9.47 US$499,997
2017-03-14 2017-03-10 B Purchase LICHTINGER PEDRO
10,559 +21.4%
9.47
US$99,994 		10,559 +21.4% 9.47 US$99,994
2017-03-14 2017-03-10 B Purchase SASSINE ANDY
21,119 +18.3%
9.47
US$199,997 		21,119 +18.3% 9.47 US$199,997
2016-08-12 2016-08-10 B Purchase Hawryluk P. Kent Non-Executive Director
25,000 +78.4%
10.00
US$250,000 		25,000 +78.4% 10.00 US$250,000
2016-08-12 2016-08-10 B Purchase Gullans Steven R. Ph.D. Non-Executive Director
500,000 +163.4%
10.00
US$5,000,000 		500,000 +163.4% 10.00 US$5,000,000
2016-08-12 2016-08-10 B Purchase Sooch Mina

President & CEO

Executive Director
52,500 +8.2%
10.00
US$525,000 		52,500 +8.2% 10.00 US$525,000
2016-08-12 2016-08-10 B Purchase MATHIESEN JEFFREY S

Chief Financial Officer

Officer
4,000 +101.9%
10.00
US$40,000 		4,000 +101.9% 10.00 US$40,000
2016-08-12 2016-08-10 B Purchase Bisgaier Charles PhD

Chair & Chief Scientific Off.

Executive Director Large shareholder
51,750 +4.3%
10.00
US$517,500 		51,750 +4.3% 10.00 US$517,500
2016-08-12 2016-08-10 B Purchase LICHTINGER PEDRO Non-Executive Director
10,000 +25.5%
10.00
US$100,000 		10,000 +25.5% 10.00 US$100,000
2016-08-12 2016-08-10 B Purchase KOUSKY KENNETH W Non-Executive Director
1,000 +inf%
10.00
US$10,000 		1,000 +inf% 10.00 US$10,000
2016-08-12 2016-08-10 B Purchase Reno Seth

Chief Commercial Officer

Officer
4,000 +inf%
10.00
US$40,000 		4,000 +inf% 10.00 US$40,000
2016-08-12 2016-08-10 B Purchase Lowenschuss David

Chief Legal Off. & Secretary

Officer
11,120 +1.4%
10.00
US$111,200 		11,120 +1.4% 10.00 US$111,200
Explore more

More insider trading research around MetaVia Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America